Background There is growing evidence that patients recovering after a severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may have a variety of acute …

The world is currently grappling with a dual pandemic of diabetes and coronavirus disease
2019 (COVID-19). Several articles published in the recent issues of Diabetes, Obesity and …

Aims/hypothesis The aim of this work was to investigate diabetes incidence after infection
with coronavirus disease-2019 (Covid-19). Individuals with acute upper respiratory tract …

Post-COVID syndrome is increasingly recognized as a new clinical entity in the context of
SARS-CoV-2 infection. Symptoms persisting for more than three weeks after the diagnosis of …

The tryptophan–kynurenine pathway (Trp–KYN) is the major route for tryptophan conversion
in the brain and in the periphery. Kynurenines display a wide range of biological actions …

Importance SARS-CoV-2 infection may lead to acute and chronic sequelae. Emerging
evidence suggests a higher risk of diabetes after infection, but population-based evidence is …

The impact of the COVID-19 lockdown on glycaemic control and other metabolic parameters
in patients with type 2 diabetes is still evolving. Aim: This systematic review and meta …

In December 2019, a pandemic emerged due to a new coronavirus that imposed various
uncertainties and discoveries. It has been reported that diabetes is a risk factor for worst …

Background This study investigated the incidences and risk factors associated with new-
onset persistent type-2 diabetes during COVID-19 hospitalization and at 3-months follow-up …

Aim To report the global, regional, and national burden of type 2 diabetes mellitus (T2DM) in
2019, assess its trends in the past, and forecast its trends in the future. Methods The main …